{"id":157281,"date":"2021-12-30T20:09:16","date_gmt":"2021-12-30T14:39:16","guid":{"rendered":"https:\/\/blog.forumias.com\/?p=157281"},"modified":"2021-12-30T20:09:16","modified_gmt":"2021-12-30T14:39:16","slug":"department-of-biotechnology-mission-covid-suraksha-supported-biological-e-limited-novel-covid-19-vaccine-candidate-corbevaxtm-receives-dcgi-approval-for-emergency-use-authorization","status":"publish","type":"post","link":"https:\/\/forumias.com\/blog\/department-of-biotechnology-mission-covid-suraksha-supported-biological-e-limited-novel-covid-19-vaccine-candidate-corbevaxtm-receives-dcgi-approval-for-emergency-use-authorization\/","title":{"rendered":"Department of Biotechnology Mission COVID Suraksha Supported Biological E Limited Novel COVID-19 vaccine candidate \u2013 CORBEVAXTM receives DCGI approval for Emergency Use Authorization"},"content":{"rendered":"\n<h5><b>What is the news?<\/b><\/h5>\n<p><span style=\"font-weight: 400;\">Drug Controller General of India (DCGI) has given Emergency Use Authorization (EUA) to the Corbevax Vaccine for Covid-19.<\/span><\/p>\n<h5><b>What is Corbevax Vaccine?<\/b><\/h5>\n<p><span style=\"font-weight: 400;\">Corbevax is<\/span> <b>India\u2019s first indigenously developed Receptor Binding Domain (RBD) protein subunit vaccine.<\/b><\/p>\n<p><b>Manufactured by:<\/b><span style=\"font-weight: 400;\"> It is manufactured by Hyderabad-based Biological E. It was supported by <\/span><a href=\"https:\/\/forumias.com\/blog\/first-nasal-vaccine-developed-by-bharat-biotech-supported-by-dbt-birac-gets-nod-of-regulator-for-phase-2-trial\/\"><span style=\"font-weight: 400;\">Biotechnology Industry Research Assistance Council (BIRAC) <\/span><\/a><span style=\"font-weight: 400;\">from pre-clinical stage through Phase III clinical studies.<\/span><\/p>\n<p><b>Financial Support: <\/b><span style=\"font-weight: 400;\">The vaccine was provided financial support under COVID-19 Research Consortium, through the <\/span><a href=\"https:\/\/forumias.com\/blog\/national-biopharma-mission\/\"><span style=\"font-weight: 400;\">National Biopharma Mission.<\/span><\/a><span style=\"font-weight: 400;\"> Later support was provided under <\/span><a href=\"https:\/\/forumias.com\/blog\/first-nasal-vaccine-developed-by-bharat-biotech-supported-by-dbt-birac-gets-nod-of-regulator-for-phase-2-trial\/\"><span style=\"font-weight: 400;\">Mission COVID Suraksha.<\/span><\/a><\/p>\n<h5><b>What is the vaccine made up of? <\/b><\/h5>\n<p><span style=\"font-weight: 400;\">It is a <strong>protein subunit vaccine<\/strong>, which means that instead of the whole virus, it <strong>uses fragments of it to trigger an immune response<\/strong>.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In this case, the vaccine contains a harmless <\/span><a href=\"https:\/\/forumias.com\/blog\/corbevax-vaccine-and-its-difference-from-other-covid-19-vaccines\/\"><span style=\"font-weight: 400;\"><span style=\"color: #0000ff;\"><strong>Spike protein<\/strong><\/span><\/span><\/a><span style=\"font-weight: 400;\">. Once the immune system recognises the protein, it produces antibodies to fight a real infection when it happens.<\/span><\/p>\n<p><b>Efficacy: <\/b><span style=\"font-weight: 400;\">The Phase III trials have <\/span><span style=\"font-weight: 400;\">demonstrated the vaccine to be safe, well tolerated and highly immunogenic.<\/span><\/p>\n<p><b>Dose<\/b><span style=\"font-weight: 400;\">: It <\/span><span style=\"font-weight: 400;\">is a 2-dose vaccine administered intramuscularly and can be stored at 2\u00baC to 8\u00baC.<\/span><\/p>\n<h5><b>What is Receptor Binding Domain (RBD)?<\/b><\/h5>\n<p><span style=\"font-weight: 400;\">A receptor-binding domain (RBD) is a key part of a virus, located on its \u2018<\/span><a href=\"https:\/\/www.news-medical.net\/health\/What-are-Spike-Proteins.aspx\"><span style=\"font-weight: 400;\">spike<\/span><\/a><span style=\"font-weight: 400;\">\u2019 domain that allows it to dock to body receptors to gain entry into cells and lead to infection. These are also the primary targets in the prevention and treatment of viral infections, including the virus that causes <\/span><a href=\"https:\/\/www.news-medical.net\/condition\/Coronavirus-Disease-COVID-19\"><span style=\"font-weight: 400;\">COVID-19<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><b>Source: <\/b>This post is based on the article<b> \u2018<\/b><b>Department of Biotechnology Mission COVID Suraksha Supported Biological E Limited Novel COVID-19 vaccine candidate \u2013 CORBEVAXTM receives DCGI approval for Emergency Use Authorization<\/b><b>\u2019<\/b> published in <b>PIB <\/b>on <b>29<\/b><sup><b>th<\/b><\/sup><b> Dec 2021.<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"<p>What is the news? Drug Controller General of India (DCGI) has given Emergency Use Authorization (EUA) to the Corbevax Vaccine for Covid-19. What is Corbevax Vaccine? Corbevax is India\u2019s first indigenously developed Receptor Binding Domain (RBD) protein subunit vaccine. Manufactured by: It is manufactured by Hyderabad-based Biological E. It was supported by Biotechnology Industry Research&hellip; <a class=\"more-link\" href=\"https:\/\/forumias.com\/blog\/department-of-biotechnology-mission-covid-suraksha-supported-biological-e-limited-novel-covid-19-vaccine-candidate-corbevaxtm-receives-dcgi-approval-for-emergency-use-authorization\/\">Continue reading <span class=\"screen-reader-text\">Department of Biotechnology Mission COVID Suraksha Supported Biological E Limited Novel COVID-19 vaccine candidate \u2013 CORBEVAXTM receives DCGI approval for Emergency Use Authorization<\/span><\/a><\/p>\n","protected":false},"author":10317,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":""},"categories":[1566,9],"tags":[3590],"class_list":["post-157281","post","type-post","status-publish","format-standard","hentry","category-daily-factly-articles","category-public","tag-pib","entry"],"jetpack_featured_media_url":"","views":{"total":0,"cached_at":"","cached_date":1700566829},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/posts\/157281","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/users\/10317"}],"replies":[{"embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/comments?post=157281"}],"version-history":[{"count":0,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/posts\/157281\/revisions"}],"wp:attachment":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/media?parent=157281"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/categories?post=157281"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/tags?post=157281"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}